Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1): A Pharmacogenomic Predictor of Response and Survival in Patients (pts) on Triplet Hepatic Artery Infusion (HAI) and Intravenous Cetuximab (Iv-Cet) for Initially Unresectable Liver Metastases from Colorectal Cancer (Ulm-Crc) (EU Trial OPTILIV).